20 Fanconi Anemia Clinical Trials in Houston, TX (2026)

Q: Are there fanconi anemia clinical trials in Houston?

Yes, there are 20 fanconi anemia clinical trials currently recruiting in Houston, TX.

Q: How do I join a clinical trial in Houston?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Houston research site will contact you.

Q: Are clinical trials in Houston free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting Fanconi Anemia Studies in Houston

NCT04677998Recruiting

A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis

The purpose of this study is to determine the efficacy and safety of a personalized surveillance and intervention protocol for duodenal and gastric polyposis in patients with familial adenomatous poly...

Houston, TX1,000 participantsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

View Study Details

NCT04678011Recruiting

A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy

The purpose of this study is to determine the efficacy and safety of a personalised surveillance and intervention protocol for patients with familial adenomatous polyposis (FAP) that have undergone (p...

Houston, TX1,000 participantsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

View Study Details

NCT06399861Recruiting

Humidity in Incubators for Tiny Infants

The objective of the study is to assess 2 different initial incubator humidification protocols for infants \<25 weeks' gestation admitted to the neonatal intensive care unit (NICU). The hypothesis is ...

Houston, TXNA900 participantsThe University of Texas Health Science Center, Houston

View Study Details

NCT04629014Recruiting

Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

This study proposes to quantify and describe the quality of life of children with intestinal failure, and to identify the medical and socio-economic factors that impact this quality of life, using dat...

Houston, TX750 participantsBoston Children's Hospital

View Study Details

NCT07164456Recruiting

Together Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their Caregivers

To establish the efficacy of the family-centered intervention in improving healthy lifestyle behaviors (MVPA and overall diet quality), as well as physical functioning, QoL, and family health climate,...

Houston, TXNA648 participantsM.D. Anderson Cancer Center

View Study Details

NCT07436299Recruiting

Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation

Heart failure and atrial fibrillation are two of the most common heart diseases globally. Nearly half of all patients with heart failure also have atrial fibrillation. When heart failure and atrial fi...

Houston, TX400 participantsOslo University Hospital

View Study Details

NCT06552637Recruiting

Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure

RECOVER HF is a clinical study designed to evaluate the safety and efficacy of Synchronized Diaphragmatic Stimulation delivered using the VisONE System in the treatment of patients with heart failure....

Houston, TXNA270 participantsVisCardia Inc.

View Study Details

NCT06532890Recruiting

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

This study aims to discover circulating microRNAs (associated with drug doses and levels) that can be used to characterize the overall immune state in pediatric heart transplant patients and predict p...

Houston, TX150 participantsInova Health Care Services

View Study Details

NCT05711732Recruiting

Busulfan Sample Collection Study

Busulfan (Busulfex®) is an alkylating drug used as a conditioning regimen prior to allogeneic hematopoietic stem cell transplantation. Busulfan has wide inter- and intra-patient pharmacokinetic variab...

Houston, TX150 participantsSaladax Biomedical, Inc.

View Study Details

NCT07462377Recruiting

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

A phase 1 study to determine the safety, tolerability, PK, PD, and preliminary anti-tumor activity of ascending doses of EPI-326 administered to patients with locally advanced or metastatic HNSCC and ...

Houston, TXPHASE1110 participantsEpiBiologics

View Study Details

NCT07547540Recruiting

A Study of LY3971297 in Participants With Heart Failure

The main purpose of this study is to assess how well LY3971297 is tolerated and what side effects may occur in participants with heart failure with preserved ejection fraction (HFpEF) and participants...

Houston, TXPHASE190 participantsEli Lilly and Company

View Study Details

NCT07721662Recruiting

Skin-to-skin Care Using the Skincubator: Feasibility and Safety Trial

The purpose of this study is to assess the impact of the Skincubator on average daily duration of Skin-to-skin Care (SSC), to assess the safety of Skincubator-supported SSC during NICU hospitalization...

Houston, TXNA60 participantsThe University of Texas Health Science Center, Houston

View Study Details

NCT05809323Recruiting

Marfan Syndrome Moderate Exercise Trial II

Marfan syndrome (MFS) is a distinctive connective tissue disorder that affects multiple organ systems including the heart, bones, ligaments, and eyes, and is associated with significant risk of aortic...

Houston, TXNA50 participantsBaylor College of Medicine

View Study Details

NCT07856641Recruiting

Circadian Variation of Anti-Factor Xa in Hospitalized Trauma Patients

The purpose of this study is to determine whether a circadian rhythm exists in anti-FXa levels and AT3 activity in hospitalized trauma patients receiving low-molecular-weight heparin (LMWH) chemoproph...

Houston, TX40 participantsThe University of Texas Health Science Center, Houston

View Study Details

NCT06831825Recruiting

Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure

This clinical trial investigates the safety and preliminary effectiveness of YAP101, a gene therapy designed to improve heart function in adults with ischemic heart failure and reduced ejection fracti...

Houston, TXPHASE124 participantsYAP Therapeutics, Inc.

View Study Details

NCT06174103Recruiting

BiVACOR® Total Artificial Heart Early Feasibility Study

The purpose of this study is to assess the feasibility of using the BiVACOR Total Artificial Heart (TAH) System to support adult patients with severe biventricular heart failure, or univentricular hea...

Houston, TXNA20 participantsBiVACOR Inc.

View Study Details

NCT06965621Recruiting

18F-mFBG Imaging for Myocardial Sympathetic Innervation

This is a Phase 2 study evaluating the positron-emitting radiopharmaceutical 18F-mFBG as an imaging agent for quantification of myocardial sympathetic innervation. The study will examine a group of st...

Houston, TXPHASE220 participantsInnervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)

View Study Details

NCT06343831Recruiting

Quantitative Assessment of Autologous Fat Transfer

This is a single-arm, prospective pilot study that will objectively assess outcomes in patients electively undergoing Autologous Fat Transfer (AFT) for breast or chest wall reconstruction. Patients pl...

Houston, TXNA15 participantsUniversity of Chicago

View Study Details

NCT06261060Recruiting

Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder

To learn about the safety and effects of low-dose sirolimus in participants with RUNX1-FPD....

Houston, TXPHASE210 participantsM.D. Anderson Cancer Center

View Study Details

NCT06414889Recruiting

Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder

To evaluate the safety and feasibility of collecting hematopoietic stem cells (HSC) in participants with RUNX1-FPD....

Houston, TXPHASE14 participantsM.D. Anderson Cancer Center

View Study Details

About Fanconi Anemia Clinical Trials in Houston

Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.

There are currently 20 fanconi anemia clinical trials recruiting participants in Houston, TX. These studies are seeking a combined 5,711 participants. Research is being sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), The University of Texas Health Science Center, Houston, Boston Children's Hospital and 12 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fanconi Anemia Clinical Trials in Houston — FAQ

Are there fanconi anemia clinical trials in Houston?

Yes, there are 20 fanconi anemia clinical trials currently recruiting in Houston, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Houston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Houston research site will contact you about next steps.

Are clinical trials in Houston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Houston studies also compensate for your time and travel.

What fanconi anemia treatments are being tested?

The 20 active trials in Houston are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.

Data updated October 12, 2026 from ClinicalTrials.gov